As little as one percent of medical research spending globally goes to female-specific conditions that aren't related to cancer. But even as underfunding of women's health persists, companies focused on women's health are innovating. Dr. Sara Naseri and the company she founded, Qvin, are working to change the stigma around menstrual blood, and to reframe it as a diagnostic tool rather than waste. It received FDA clearance in January of this yearfor a new kind of blood test: a diagnostic menstrual pad.
Plus, Axios senior health care editor Adriel Bettelheim on innovations in women's health.
Guests: Dr. Sara Naseri,CEO and co-founder of Qvin; Axios' Adriel Bettelheim
Credits: 1 big thing is produced by Niala Boodhoo, Alexandra Botti, and Jay Cowit. Music is composed by Alex Sugiura and Jay Cowit. You can reach us at [email protected]. You can send questions, comments and story ideas as a text or voice memo to Niala at 202-918-4893.
